Lobofyl is a biotechnology platform company developing next-generation programmable detection technologies for research and translational applications. Our platform combines engineered binding proteins, fluorescent detection systems, and scalable manufacturing workflows to create reproducible, sequence-defined reagents that help researchers generate more reliable and transferable results. Building on the foundation of FluorAbody® and Split-Fluorescent Protein technologies, we are creating a modern toolkit for target detection, assay development, and future diagnostic partnerships. Our focus is on improving reproducibility, standardization, and accessibility while enabling new opportunities for collaboration across academia, biotech, and industry. Resource Center: https://app.notion.com/p/Resource-Center-38fbab06da498042b4d8c6025b1346a4
| Website | http://lobofyl.com |
| Employees | 1 (1 on RocketReach) |
| Founded | 2026 |
| Industry | Biotechnology Research |
Looking for a particular Lobofyl employee's phone or email?
Michael Humbert is the Founder and CEO of Lobofyl.
1 people are employed at Lobofyl.
Lobofyl is based in Albuquerque, New Mexico.